by Fatma Niang | July 04, 2022
How Fragmented Oversight Harms Veterans Key Takeaways The Veterans Health Administration (VHA) struggles to provide quality care to veterans, due to various issues ranging from inadequate staffing, safety concerns, to lack of efficiency. The GAO has attested that the VA faces an ongoing struggle in the oversight of their healthcare
by John Moore | June 14, 2022
Oracle Aims (Too) High with Cerner Acquisition Announcements By last Thursday, Oracle had closed its much-anticipated acquisition of Cerner. The next day, Oracle hosted a webinar to discuss their vision and intentions for Cerner and more broadly, Oracle in healthcare. The big visionary picture was provided by none other than
by John Moore | January 06, 2022
The Future of Clinician-Centric Innovation Much has been written about this $28.3 billion monster acquisition. Most articles focused on what this means for Oracle and Cerner, yet little has been said as to what this may mean to the broader healthcare IT sector. In my musings below, I hope to
by Jody Ranck | August 30, 2021
Key Takeaways The ONC is advancing the creation of standards for social determinants of health (SDoH) data as a priority in their efforts to improve outcomes and population health. USCDI (United States Core Date for Interoperability) version 2 guidance was recently released and is including SDoH, gender identity and sexual
by Brian Murphy | March 23, 2021
In this Hot Take, our Director of Research, Brian Murphy, digs into a timely example of one of the important ways healthcare interoperability is currently lacking: easily accessible immunization records. As the COVID vaccine rollout accelerates, the need to have vaccination status as a retrievable data point in patient health
by John Moore | February 17, 2021
There appears to be a new Gold Rush in healthcare IT to leverage (sell) patient data to Life Science companies: Cerner is coming to market with its Learning Health Network (LHN);Fourteen health systems are coming together to launch Truveta;Allscripts has been at it for a few years with Veradigm;Health Catalyst
by Chilmark Team | December 18, 2020
Unlike past years when we have written a post evaluating how well our predictions for that year held up, let’s just say the COVID pandemic threw a monkey wrench into everything and move on. That being said, before I started pulling these predictions for 2021 together with the Chilmark Research
by Chilmark Team | December 01, 2020
John Moore, Alex Lennox-Miller, Jody Ranck, Brian Murphy Roughly a year ago, athenahealth held its first analyst event. This event came on the heels of athenahealth’s protracted battle with an activist investor that ultimately took the company private and led to the exit of their flamboyant CEO, Jonathan Bush. That first
